Applications & products
How Claude is accelerating protein design and analytical chemistry
Claude’s reported campaign produced binders for 14 of 15 evaluated targets; a separate Opus 5 run processed raw NMR and LC-MS files in minutes, with results matching the lab’s measurements.
Why it matters: The reported gains address two time-consuming parts of early research: designing binders and interpreting instrument files. They suggest where AI could reduce hands-on analysis and computational effort, while leaving therapeutic development and the need for further validation unresolved.